Based on our findings on the importance of the S100A4-RAGE interaction, therapeutic approaches targeting RAGE or intervening in RAGE dependent signaling early in tumor progression might represent alternative strategies restricting the S100A4-induced metastasis in CRC. This evidence concerns the gene AGER and colorectal carcinoma.